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Abstract
WHO estimates that 80% of mortality due to malaria occurs among infants and young children. Though it has long
been established that malaria disproportionately affects children under age five, our understanding of the
underlying biological mechanisms for this distribution remains incomplete. Many studies use age as an indicator of
exposure, but age may affect malaria burden independently of previous exposure. Not only does the severity of
malaria infection change with age, but the clinical manifestation of disease does as well: younger children are
more likely to suffer severe anaemia, while older children are more likely to develop cerebral malaria. Intensity of
transmission and acquired immunity are important determinants of this age variation, but age differences remain
consistent over varying transmission levels. Thus, age differences in clinical presentation may involve inherent age-
related factors as well as still-undiscovered facets of acquired immunity, perhaps including the rates at which
relevant aspects of immunity are acquired. The concept of “allometry” - the relative growth of a part in relation to
that of an entire organism or to a standard - has not previously been applied in the context of malaria infection.
However, because malaria affects a number of organs and cells, including the liver, red blood cells, white blood
cells, and spleen, which may intrinsically develop at rates partly independent of each other and of a child’s overall
size, developmental allometry may influence the course and consequences of malaria infection. Here, scattered
items of evidence have been collected from a variety of disciplines, aiming to suggest possible research paths for
investigating exposure-independent age differences affecting clinical outcomes of malaria infection.
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Background
In 2009, an estimated 243 million cases of malaria led to
approximately 863,000 deaths around the world, 80% of
which WHO estimates were in infants and young chil-
dren [1]. It is widely known and accepted that children
are at increased risk for severe disease and death
between six months and five years of age. Many studies
have attempted to decipher which aspects of the para-
site, host, and external environment lead malaria infec-
tion to severe disease in some, yet remain asymptomatic
in others. Although acquired immunity plays a large
role in protection, the host’s age, apart from prior expo-
sure, may independently influence the infection’s sever-
ity. This paper considers the possibility that, for
instance, in young children malaria parasites are attack-
ing populations of erythrocytes that are intrinsically
smaller, in hosts whose immune responses are
intrinsically lower, slower or less durable, and that these
features might have clinical correlates.
The Plasmodium falciparum parasite life cycle begins
when an Anopheles mosquito injects sporozoites into
the human host. The parasites travel through the blood-
stream into the liver, where they invade and replicate,
releasing approximately 30,000 merozoites per hepato-
cyte [2]. The merozoites invade erythrocytes (red blood
cells: RBCs). The parasite remains in the erythrocyte for
about 48 h, maturing through the ring, trophozoite, and
schizont stages, at which point the RBC bursts and
releases 8 - 32 new merozoites that invade new RBCs.
From the trophozoite stage until it bursts, the infected
RBC typically adheres to endothelium and so is seques-
tered, out of circulation. After a few such cycles, clinical
symptoms may begin to appear. A small portion of
invading merozoites become gametocytes, the sexual
phase of the parasite [3], which can infect a biting mos-
quito and continue the transmission cycle.
Severe P. falciparum infections typically present two
distinct clinical manifestations: severe malarial anaemia
(SMA) or cerebral malaria (CM). In both, severe disease
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any medium, provided the original work is properly cited.is generally associated with higher levels of parasitaemia
and consequently exaggerated pathogenesis of infection,
including rosetting (in which 10 or more uninfected
cells clump together around a single infected RBC),
cytoadherence, and increased clearance of both infected
and uninfected RBCs, discussed in detail below. SMA is
associated with high peripheral parasitaemia, low hae-
matocrit, and decreased haematopoiesis [4]. Increasing
levels of parasitaemia are associated with decreasing
levels of haemoglobin, suggesting a causal relationship
between parasitaemia and SMA [5]. SMA in children
under five may be more common in boys, although the
reason is unknown [6]. Changes in RBCs with host age,
such as size, density, overall number, and surface chemi-
cal properties may influence pathogenesis. In addition,
host factors affecting RBC production and clearance,
including spleen structure, may affect anaemia severity.
Despite numerous studies and the identification of
several significant contributing factors, the pathogenesis
of CM remains somewhat opaque. Although parasitae-
mia and CM appear correlated, no causal relationship
between degree of parasitaemia and CM has been firmly
established [7,8]. Many studies point to erythrocyte
sequestration in the brain as important, although this
has not been observed in all cases. However, the pre-
sence of infected RBCs in retinal capillaries is strongly
associated with CM [9], and fatalities putatively due to
CM, but without erythrocyte sequestration, can be
attributed to other infection-related causes [9,10]. Cere-
bral clinical manifestations may arise from RBC rosettes
cytoadhering to endothelium, clogging blood flow to
and within the brain [11]. Platelets may have a signifi-
cant role in the attachment of infected RBCs to the
brain endothelium [12]. In addition, it has been noted
that CM in children presents differently than in adults.
In adults, convulsions are rarely observed, coma arises
after a few days of gradual decline, and fatal outcomes
are typically due to renal failure, liver failure or pulmon-
ary oedema [13]. In children, coma arises quickly, and
there is increased permeability of the blood brain barrier
(BBB), raised intracranial pressure, and cerebral oedema
[14]. Convulsions are observed in the majority of chil-
dren with CM, and neurological sequelae are observed
more frequently in children than adults [13]. Although
the pathogenesis remains unclear, developmental
changes may affect the risk for and outcome of CM:
propensity for erythrocyte sequestration, cytoadherence,
and rosetting may be influenced by RBC size, surface
proteins, and deformability. Changes in the size of the
brain, cerebral blood flow, and myelination may affect
clinical manifestation as well.
Numerous studies have shown that the severity of
malaria infection, as well as its clinical manifestations,
changes with age. The incidence of severe anaemia and
cerebral malaria is higher in children [15-17], and
younger children are more likely to suffer SMA, while
older children are more likely to develop CM [18-21]. In
areas of high endemicity, severe malaria is uncommon
after age five, at which point the risk for symptomatic
malaria falls significantly as well. Across all levels of
transmission intensity, CM appears to be uncommon in
children, especially those under four, suggesting the pre-
sence of “age-dependent physiological factors that oper-
ate independent of acquired immunity” [21]. Thus age
differences in clinical presentation may involve inherent
age-related factors as well as still-undiscovered facets of
acquired immunity, perhaps including rates at which
relevant aspects of immunity are acquired [22].
This paper explores the concept of “allometry” -t h e
relative growth of a part in relation to an entire organ-
ism or to a standard - as a possible explanation for
some age-related differences in malaria infection. Since
malaria affects a number of organs, including the liver,
red blood cells, white blood cells and spleen, all of
which may develop at rates independent of each other
and of the child’s overall size, each may influence the
course and consequences of malaria infection differently
at different times. For example, children have a much
larger liver mass in relation to body weight than adults,
which may influence the rate at which drugs and toxins
are metabolized and cleared, and thus the strength of
their effects [23]. The non-linear scaling of liver to body
mass during development means that paediatric drug
dosages calculated as simple fractions of adult dosages,
corresponding to relative body mass, could be ineffective
or dangerous. Similarly, for drugs cleared through the
kidney, it may be important to consider the different
rates at which different kidney functions mature: glo-
merular filtration reaches adult levels at six to 12
months of age, while tubular secretion requires one to
five years [24]. Hence allometry is an object of ongoing
research and debate in pharmacology and toxicology, as
it is in nutrition, evolutionary biology and many other
fields (see Additional file 1 and Figure 1). This paper
collects scattered items of evidence from a variety of
disciplines, aiming to suggest possible research paths for
investigating exposure-independent age differences
affecting clinical outcomes of malaria infection (as sum-
marized in Figure 2).
Exposure vs age
In areas of high endemicity, children between six
months and five years of age develop the most severe
clinical response to infection, while in areas of low
endemicity, older children and adolescents are most at
risk [17]. The first one or two infections are the most
severe; particularly in highly endemic areas, age is often
used as a surrogate first approximation for exposure,
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Many studies use age as an indicator for both. However,
though transmission intensity and acquired immunity
must be important factors in age-varying responses
[16,17,21,26], some age differences remain consistent
over varying transmission levels, apparently independent
of previous exposure.
In areas of high transmission compared to low trans-
mission, children develop protection against severe clini-
cal malaria at early ages and less often present with CM,
while adults rarely develop symptoms [27]. Separating
exposure-dependent from exposure-independent age-
related factors is extremely difficult, but a set of epide-
miological studies of Indonesian transmigrants
attempted to do so [28-30]. Among families relocated
from Java, an island with little or no P. falciparum
transmission, to holo-endemic Irian Jaya, the previously
unexposed Javanese children and adults showed unique
patterns of malaria symptoms relative to each other and
to age-matched locals. In local residents, younger chil-
dren had more frequent and more severe infections
than did adults, as would be expected. The transmigrant
children and adults had similar incidence of infection
upon initial measurement; however, after three months
of residence the prevalence of clinically severe malaria
was significantly higher in adults than in children. After
one to two years, adult migrants had less frequent and
less severe infections than their children who had
experienced the same exposure to infection, indicating
that they had acquired immunity more rapidly than
their children. Thus, apparently, among non-immunes
the risk of severe malaria increases with increasing age,
but after a period in an endemic area this is offset by
rapid acquisition of immunity with increasing age. This
result has been supported by other studies suggesting
that significant protective factors arise during develop-
ment, apart from previous exposure [31,32].
Age-related changes in blood and red blood cells
A number of important and possibly clinically relevant
changes occur in blood and red blood cells during
infancy and early childhood: a switch from foetal hae-
moglobin (HbF) to adult haemoglobin (HbA), a shift in
the overall age profile of RBCs due to different rates of
production and decay, and changes in overall blood
volume, cell size and cell surface proteins.
It is difficult to isolate the possible protection of HbF
due to potentially confounding variables in infants
under six months of age, such as nutritional differences
(e.g. nursing) or transferred maternal antibodies, which
occur in similar time frames [33]. For instance, there is
evidence that breast milk lacks p-aminobenzoic acid, a
critical nutrient for parasite survival [33]. Maternal anti-
bodies transferred during gestation have also been
shown to contribute to protection of young infants [34].
After this initial period of protection, children in
endemic areas become highly susceptible to severe
infection. Progression from infection to severe disease
and death can be very rapid, particularly in small chil-
dren. The simple number of available RBCs may be a
contributing factor in this progression. Presumably, the
biological process of parasite invasion and multiplication
in RBCs is independent of the age of the host during
malaria infection (i.e. the parasite does not “know” the
age of its host). As a child grows, its blood volume
grows at a rate correlated with lean body mass [35,36].
Haematocrit and RBC concentration increase slightly
with age, suggesting that if the overall blood volume
and RBC concentration increases, the absolute number
of RBCs must increase as well [37,38]. Thus, as
expected, there are fewer RBCs in a small child than in
an older child or adult, such that the same number of
Figure 1 Developmental growth curves. Developmental growth
curves of different parts and tissues of the human body, each
plotted as a percentage of the total gain from birth to 20 years of
age (i.e. size at age 20 is 100 on the vertical scale). Height and most
body measurements follow the “general” curve. Note that the brain
(and the head containing it) develops earlier than any other tissue;
at birth it is already 25% of its adult weight, and 90% at age five.
Lymphoid tissue reaches its maximum just before adolescence, and
then declines to its adult value as the reproductive organs rapidly
increase. (Drawn after Scammon, 1930 [25]).
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the same number of new host cells are infected during
each replication cycle of the parasite, the percentage of
host RBCs that are infected must increase more rapidly
in a child than in an adult (Figure 3). This idea is sup-
ported by observations that younger children develop
higher parasitaemia more quickly than older children
and adults [39-41]. In a small child the proportion of
RBCs infected can increase to more than double that of
an adult in just a few days (Figure 3). The smaller pool
of available RBCs in a small child and the rapid replica-
tion cycles of the parasite shorten the time available to
the immune system to respond to the infection, and the
time window for treatment, leading to increased severity
and fatality of infection.
The rate of RBC clearance increases disproportionately
during P. falciparum infection: as many as nine to 10
uninfected cells may be cleared for every infected cell, a
phenomenon known as the “bystander effect” [44]. It is
not known why so many uninfected RBCs are cleared dur-
ing infection; there are minimal observable surface
Figure 2 Summary of the overall changes with age.
Figure 3 Percentage of infected RBC. The percentage of infected RBCs in the total number of RBCs in a child’sa n da d u l t ’s body. The total
number of RBCs is correlated with average body mass [42,43]. Assuming that the parasite replicates at a constant rate independent of the host,
smaller children will have a higher parasitaemia within a given time period. Each cycle is 48 h; therefore cycle 5 occurs 240 h after the parasite is
released from the liver.
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causes antibody sensitization of all RBCs, or that infected
RBCs release substances that cause subtle surface changes
or reduced deformability of uninfected RBCs [[45,46], and
references therein]. Another possibility is that uninfected
cells that attach to infected ones are cleared [47]. Since
small children have fewer RBCs, and a higher ratio of
infected RBCs to uninfected RBCs, this increased rate of
clearance removes a larger percentage of the total RBC
population, and so may contribute further to the severity
of anaemia in younger children [48].
The rate of production of RBCs differs between chil-
dren and adults. Since young children are growing at a
faster rate than adults, and increasing their blood
volume in proportion to their lean body mass, they
must produce erythrocytes at a faster rate to keep up.
At birth, all bone marrow is RBC-producing red mar-
row, but this proportion continually declines until, in
adulthood, only half is red marrow [49]. In infancy and
early childhood bone marrow is the main source of RBC
production, however after age five production in the
long bones steadily declines until puberty [50]. Thus
growing children should have a higher proportion of
younger RBCs, and P. falciparum (as well as Plasmo-
dium vivax) preferentially infects young RBCs [51].
Furthermore, malaria has been shown to adversely affect
erythropoesis. Though dyserythropoesis has an overall
small effect on RBC density [52], its effect on children
may be larger due to these developmental factors.
Age-related differences in total cerebral blood flow
(tCBF) and regional cerebral blood flow (rCBF) may
contribute to observed clinical patterns of CM. tCBF
increases drastically within the first few years of life and
then gradually declines to adult levels [53]. White mat-
ter blood flow peaks between six and 8 months of age,
and grey matter blood flow peaks between three and
four years of age. The flow to grey matter averages
about three times that of white matter, and as a result
the overall CBF follows the pattern of grey matter blood
flow. At birth, tCBF accounts for about 15% of cardiac
output, and peaks around age four, when it accounts for
55% of cardiac output. It then gradually declines to
adult levels of 15% [54]. In addition, significant changes
in rCBF have been observed with age as different areas
of the brain grow [55].
A recent study of fatal paediatric CM cases showed
that CM affected both the white and grey matter,
although most haemorrhages occurred in the white mat-
ter. The increase in CBF with age may predispose older
children to clogged blood flow and haemorrhaging. In
addition, the majority of cases had a significant increase
in brain weight due to oedema compared to that of an
uninfected child of the same age, a trend which was not
observed in fatal adult cases [56].
Myelination, the process of adding myelin around
neural axons, begins before birth and continues through
adolescence [57]. Given that paediatric CM is associated
with significant damage to myelin [53], it may be that
the consequences of this destruction vary with the
increasing levels of myelination with age. Although most
patients fully recover from CM, long-term effects occur
more frequently in children than adults [58]. Children
develop symptoms of the central nervous system and
most present with convulsions, while adults develop
multi-organ failure, and very few have convulsions
[58,59]. Although the detailed pathogenesis of CM
remains unknown, these age-related changes in CBF,
combined with rosetting and brain development, may
affect a child’s disposition to CM [11].
In addition to the overall change in blood volume and
flow, mean red cell volume (MCV) increases with age
[15,60]. How RBC size variation affects the parasite’s
growth and development or clinical manifestations of
malaria is unknown, but the RBC size difference may
have several consequences. First, cell size may inherently
affect invasion probability. Second, assuming that para-
site growth is independent of host cell size, cell size may
influence internal pressure or the capability for expan-
sion, which affects deformability. When a host is
infected with P. falciparum, both infected and unin-
fected erythrocytes lose deformability, exaggerating
these effects [61]. Because viscoelasticity has been
shown to be consistent between uninfected children and
adults, these differences are assumed to be the result of
parasite infection [62].
These reductions in size and deformability of RBCs
change blood flow dynamics and decrease the ability of
a RBC to fit through the splenic filter (see below) [63].
The smaller MCV of young children may influence the
deformability of infected RBCs, which may affect splenic
filtration, increasing RBC destruction and aggravating
anaemia [32,64,65]. Recent research suggests that the
spleen is able to clear more cells in younger children,
due to their cells’ smaller MCV, which may contribute
to the increased incidence of SMA in this group [32].
This could be further accentuated during an infection
by decreased deformability of smaller infected cells rela-
tive to larger RBCs. The increased rate of clearance may
lead to an increased clearance of infected RBCs, but
may exacerbate SMA due to an increased clearance of
uninfected RBC, further reducing the total number of
RBCs.
There is evidence to suggest age differences in surface
proteins on RBCs, which impact both binding properties
and recognition by the spleen [66]. Age-related varia-
tions of erythrocyte surface proteins may lead to differ-
ences in the ability and tendency of the cells to rosette
and cytoadhere, both possible mechanisms for CM
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protein involved in mediating phagocytosis and immune
adherence, and has been associated with rosetting. One
recent study, across three distinct regions of varying
transmission patterns, reported an increase with age in
levels of CR1 (CD35), most significantly in young chil-
dren. This increase occurred at earlier ages and more
drastically in malaria-free compared to endemic areas
[68]. The increase in CR1 with age may increase a
child’s susceptibility to CM during growth.
Two other complement proteins, CD55 (decay-accel-
erating factor) and C3b, are age-dependent and have a
significant role as part of the innate immune system
during malaria infection [69]. CD55 blocks the mem-
brane-attacking complex, and thus immune destruction
[70,71]. CR1 activates C3b, which has many roles
including the removal of immune complexes. CD55
inhibits the functioning of the C3 cascade, preventing
C3b deposition [69,72]. CD55 levels are lowest in early
childhood, and steadily increase through adulthood [73].
C3b levels are highest in early childhood, and decline
through adulthood [69]. C3b deposition is associated
with increased RBC removal and destruction. Both the
presence and density of parasitaemia significantly
increase C3b deposition, although the effect of density is
not as significant as that of mere presence. The age-
associated imbalances of low levels of CR1 and CD55
and high levels of C3b may increase RBC destruction
and aggravate SMA in young children [69]. As CR1 and
CD55 levels increase in slightly older children, they may
increase susceptibility to CM due to their role in
rosetting.
The complement cascade, as well as the surface pro-
tein CD36, has also been associated with platelet activa-
tion. CD36 is present on platelets, macrophages,
dendritic cells (DCs), and some endothelium. PfEMP1, a
protein expressed by P. falciparum,b i n d st oC D 3 6a n d
is responsible for sequestration of parasites. However,
CD36 is not present on brain endothelium and is not
responsible for sequestration of parasites in the brain
during CM. Rather, it is thought that PfEMP1 binds to
platelets, which then secrete cytokines activating the
brain endothelium, or, perhaps, themselves bind to
endothelium. Some studies have shown an increase in
platelet count in the brain during cerebral infection,
compared to those without cerebral malaria, possibly
due their role in cytoadherence [74]. Thrombocytopae-
nia is frequently associated with severe malaria infection
and disease [75]. It is not clear whether the decrease in
platelet count is due to a decrease in production,
increased clearance from circulation, or sequestration in
the brain and spleen. The specific role of platelets in
malaria remains unclear, but there is some evidence
relating the severity of thrombocytopaenia with the
outcome of infection [76]. Although the “normal” plate-
let count has a wide range across ages, the accepted
normal range is higher in infants and young children
than in older children and adults [37]. If platelets are
critical for cytoadherence in the brain and are a rate
limiting step in sequestering parasites in the brain capil-
laries in very young children, increased platelet count
with age may increase susceptibility to CM.
In addition to the cells themselves, blood vessels may
change in size or chemical properties with host age,
influencing blood flow, cytoadherence, and parasite
clearance rate. For example, there is evidence that levels
of VCAM-1, a cell-adhesion molecule important in
malaria, decrease throughout childhood, but research on
such changes across ages is still sparse [77].
I ns u m m a r y ,H b F ,s m a l lM C V ,i n h e r e n ts i z ed i f f e r -
ences (total blood volume and blood vessels) and surface
concentrations of CR1, CD55, and C3b that change dur-
ing infancy and early childhood may increase suscept-
ibility to SMA. These same size differences and changes
in CBF and platelets may increase susceptibility to CM
with age.
Finally, there may be interaction between clinical fea-
tures of SMA and CM. SMA might provide some pro-
tection against CM by reducing the number of RBCs in
circulation. If CM is significantly related to rosetting, a
reduction in the number of total RBCs, and thus their
concentration, would reduce the probability of the cells
contacting each other and forming a cluster [46,78].
Although many studies show co-occurrence of CM and
SMA at expected levels [40], significant negative associa-
tion has also been observed [79]. Patients with low
packed cell volumes have a significantly lower frequency
of presenting with CM than those with higher packed
cell volumes [80].
The spleen
The spleen filters RBCs, and destroys them if infected or
senescent. The spleen clears RBCs through two distinct
structural mechanisms: physical selection and cell-cell
interaction. The spleen is composed of the red pulp,
where mechanical filtration occurs, and the white pulp,
where most contact with immune-system cells occurs
[81]. The spleen also contains the marginal zone, the
region bordering the red pulp and white pulp, which
contains macrophages especially important for targeting
polysaccharide-encapsulated bacteria [82].
To filter RBCs, the spleen uses both fast microcircula-
tion, a closed vascular system, and slow microcircula-
tion, an open system in which RBCs enter a large pool
and must filter through the cords in the red pulp and
the endothelial cells. Ten to 20% of RBCs are continu-
ously filtered through slow microcirculation; their suc-
cessful passage depends on the deformability of the cell
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120 days, changing physically and chemically with age in
ways that affect predisposition for splenic clearance. In
older RBCs, the volume of water decreases, but the hae-
moglobin level remains stable, increasing the density
and decreasing deformability [83]. During malaria infec-
tion, RBCs exhibit these same changes [63]. As parasites
grow, the deformability of the cell decreases. So, in the
slow, open microcirculation it may be that the spleen
retains and destroys infected RBCs due to this change in
density [84]. Malaria infected erythrocytes may also be
“pitted” in the slow microcirculation of the spleen [85].
Pitting removes the parasite from the cell, and then
returns the cell into circulation.
Foetal RBCs have a shorter lifespan due to differences
in haemoglobin chemistry, enzyme concentration, and
surface proteins [86] that may make them more suscep-
tible to splenic clearance. It is possible that the initial
size and haemoglobin composition of the cell affects
changes in deformability. The smaller MCV and higher
content of HbF of young children may be a factor in the
increased frequency of SMA. The spleen may clear
more infected and uninfected cells as a result of this
initial size difference, and the consequently exaggerated
reduction of deformability during infection.
Splenomegaly is common in malaria infection, some-
times extreme to the point of rupture, and has been
associated with increased rates of clearance of infected
erythrocytes in mice [87,88]. The physical limitations of
swelling are unknown, but it is possible that initial
spleen size, correlated with age, affects the maximum
rate of infected RBC filtration.
Structural differences between infant and adult spleens
may contribute to differences in clinical response to
infection. Both the marginal zone and red pulp seem to
take part in the clearance of infected RBCs, but the mar-
ginal zone only begins to appear about 8.5 months after
birth, and is not fully developed in human infants until
age two [89,90]. The marginal zone B cells are known
for their role in T-independent responses, and young
infants cannot produce T-independent (TI) antibody
responses, possibly due to this immature architecture
and an absence of natural memory B cells (discussed
below) [90]. However, at least in mice, marginal zone B
cells also produce IgM within a few days of antigen pre-
sentation [91]. In spleens from splenectomized humans,
B cells in the marginal zone also produced IgM. How-
ever, there were few IgM-only producing B cells,
although more in children under five years of age [92].
Immaturity of the spleen has been noted to cause obser-
vable differences in the immune responses of young
children, especially in response to polysaccharide anti-
gens, and is likely to influence responses to malaria
infection.
The immune system
A host of any age responds to infection by attempting to
destroy the multiplying parasite, but the capacities of
immune and other response systems may be more lim-
ited in infants. The immaturity of the immune system in
neonates is widely recognized, in general terms [93-96].
Young infants do not respond well to T-independent
polysaccharide antigens, and create a weaker response
than older children and adults to T-dependent protein
antigens [93]. This observation may be due to the lack
of a marginal zone in the spleen in young children. Age-
related differences in immune responses can be
observed on a clinical level, for instance in the greater
susceptibility of younger people to environmental toxins
[97]. Specific causes for these observations remain
unknown, but some developmental differences have
begun to be recognized.
Though some vaccines given to newborns and young
infants work well, others do not elicit effective, durable
protection, presumably due to the presence of passively
transferred maternal antibodies, weak and abbreviated
antibody responses and developmental differences in T-
cells and antigen-presenting cells. There seems to be
some contribution of both genetics and environment in
the patterns of early cytokine response [98]. When
Meningococcus C and diphtheria vaccinations are given,
even multiple times, the resulting antibody titer declines
much more rapidly in infants than adults [99]. As
another example, a study in lab mice that compared six
vaccines containing the same antigen but different adju-
vants found that the most effective in infant mice was
least effective in adults [93]. These specific examples
indicate that there is some overall immune immaturity,
the specifics of which remain unknown, that may also
affect infant responses to malaria infection.
Plasmodium infection triggers both innate and
acquired immune responses. Because the ratio of naïve
cells to memory cells declines as the human matures,
due to cumulative foreign antigen exposure, it is difficult
to differentiate the effects of age per se and previous
exposure on these responses [100]. Exposure to malaria
also stimulates memory cells that protect the body from
future encounters with the same antigen. However,
because not all malaria infections become symptomatic,
whatever the age of the host, scientists cannot rely on
c l i n i c a ls i g n sa sa ni n d i c a t ion of exposure, and must
instead undertake proactive studies of serology.
Cell-mediated response
The thymus loses its functionality with age, slowing T
cell production and differentiation. In fact, the rate of T
cell production peaks in early childhood. Maximum thy-
mic cellularity occurs between six months and one year
of age, at which point it begins a slow, steady, decline
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rate around puberty [101,102].
The immune system includes Th1 CD4+ T cells and
Th2 CD4+ T cells among several other T cell subsets. T
regulatory (Treg) cells control the differentiation and
function of T cells, regulated by the transcription factor
Foxp3, as well as the cytokine environment [103]. A
balanced capability to produce both Th1 and Treg
responses is essential to control malaria infection.
Infants do not mount sufficient Th1 responses to infec-
tions in general, however, which creates a skewed
response. It is thought that the Th1 response is
restrained until the capacity to make T regulatory
responses has developed, protecting the infant from
potentially dangerous runaway inflammatory immune
reactions [103]. The Th2 bias is due to some aspect of
the regulatory network that is immature, perhaps influ-
enced by passively transferred maternal antibodies [98].
Infants have a higher concentration than adults of
recent thymic emigrants (RTEs) circulating in the per-
iphery [104]. As a growing host is exposed to common
pathogens over time, the repertoire of circulating CD4+
T cells expands. Increasing numbers of memory T cells
with increasing age may increase the potential for
“cross-reactive” bystander activation of Th1 cells, leading
to more inflammation and thus more CM. As the regu-
latory responses develop into later life, this balance may
be redressed, reducing the risk again [105].
Neonates and young infants produce a Th2 response
to antigens but gradually shift to a dominant Th1
response with age [106]. Both too much and not enough
Th1 response are associated with severe disease
[106,107]. Though the reasons for the Th2 bias in
infants and young children remain unknown, the imma-
turity of their DCs may be a key factor [108,109]. Recent
evidence indicates that DCs release cytokines recruiting
Th2 memory cells upon activation [110]. DC popula-
tions are smaller in infants than adults both in absolute
terms and relative to their smaller size [111]. The num-
ber of circulating myeloid DCs and plasmacytoid DCs
was significantly lower in 12-month olds compared to
adults [111]. Infants have a much higher proportion of
immature DCs than adults, as indicated by studies of T-
cell activity [111].
The inflammatory cytokine TNF-a is associated with
cerebral malaria, and it is possible that the bias against
producing a Th1 response in young children - whether
it is due to inherent age-related properties or exposure
and environment - helps to protect them from develop-
ing cerebral malaria [93,109]. Exposure to malaria
causes infants and young children to produce relatively
heightened Th1 responses for their ages, which may
help to explain the slightly earlier age of observed cere-
bral malaria cases in holo-endemic regions [22].
Humoral response
The Th2 CD4+ T cell bias in infants influences the pro-
portions and levels of cytokines produced, and may
affect which antibodies are produced in response to an
infection by influencing different B cells [28]. Typically,
immunoglobulin M (IgM) is the primary antibody, pro-
duced during first exposure to an antigen, and IgG is
produced upon subsequent exposure. The baseline con-
centration of IgG in the blood, nominally in the absence
of infection, increases throughout childhood and adoles-
cence [112].
The subclass of IgG response - IgG1 or IgG3 - varies,
but the cause of this variation remains unclear. Some
research indicates that in malaria the subclass varies by
P. falciparum a n t i g e n .B u tt h e r em a yb em o r ei n v o l v e d
than the antigen presented. One study showed that chil-
dren trigger an IgG1 response to the MSP-2 (merozoite
surface protein-2) antigen, while their maternally-
derived antibodies to MSP-2 were IgG3 [113]. Infant B
cells have been shown to produce quantitatively lower
IgG and IgM responses than adults to “protein or conju-
gate vaccine antigens” [93]. Infants have also been
shown to produce a lower response to most T-depen-
dent antigens; although the diminished response is most
evident in TI antibodies and IgG subclass IgG2, it has
also been observed in IgG3 [114].
T h eI g G 3r e s p o n s et oM S P - 2s e r o g r o u pAi sh i g h l y
correlated with clinical immunity to P. falciparum,s o
t h ep o s s i b l yd i m i n i s h e da n t i b o d yr e s p o n s ea n dI g G 1
bias in children might be involved with increased sever-
ity of disease in infants and young children [115]. How-
ever, these studies do not distinguish whether previous
exposure or developmental immaturity cause this shift
in antibody quantity and subclass.
Another recent study found that adult non-immune
travelers had a strong IgG1 (rather than IgG3) response
compared to immune adults during infection, suggesting
that previous exposure is a significant factor in deter-
mining the IgG1 vs. IgG3 response [116]. However,
there are still differences by age in the rate of acquisi-
tion of the different antibody subclasses [116]. Recent
research has begun to try to differentiate the acquired
responses to P. falciparum b a s e do na g ea n dt h ei n t e n -
sity of transmission. One study looked at the ratio of
IgG1/IgG3 response across four different levels of trans-
mission, and showed that age and endemicity both inde-
pendently increase IgG1 subclass at younger ages and
increase IgG3 with age for anti-MSP-2 antibodies [117].
There is evidence that the persistence of antibodies, as
well as the rate of production, increases with age. A
recent study in the Gambia found that the half-life of
antibodies to an array of P. falciparum antigens in older
children (ages four to six) was three times that of
younger children (ages one to three) during and after
Billig et al. Malaria Journal 2012, 11:64
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children found that the half-life of their antibodies was
much shorter than in healthy adults, and yet another
found that the quantity of these same antibodies
declined in all age groups, but to about half the level in
the younger age groups within the same time interval
[119,120]. The differing initial levels of antibodies and
differing rates of decay with age lead to significant dif-
ferences in antibody level over time, following initial
antigen exposure (Figure 4).
This concept of varying half-lives is further supported
by evidence that IgG levels in children have been shown
to fluctuate seasonally, while the levels of antibodies in
adults remained much more stable [119,122]. This dif-
ference may be caused by shorter-lived plasma cells, so
that the child’s recognition of an antigen does not per-
sist as long as an adult’s, and consequently the plasma
cells fail to continue secreting IgG.
Long-lived plasma cells are necessary to provide an
extended effective response to (non-chronic) infection,
but are apparently lacking in young children [93,123], as
they are in infant mice [124]. Both long-lived and short-
lived plasma cells produce antibodies, but it is the long-
lived plasma cells that sustain levels of antibodies during
p e r i o d so fl i t t l eo rn oe x p o s u r et oi n f e c t i o n .M e m o r yB
cells are potential plasma cells, pending repeat exposure
to antigen; long-lived memory B cells function for long
periods of time independently, and are needed to renew
the pool of short-lived and long-lived plasma cells. The
duration of antibody response after a single exposure
may provide insight into which plasma cells are secret-
ing the antibodies. Recent evidence suggests that malaria
disease may induce changes in the levels of B-cell acti-
vating factor (BAFF), which has an important role in B-
cell differentiation and the maturation of long-lived
plasma cells, possibly further complicating the develop-
ment of immune responses in young children [125].
Thus, the combination of different rates of antibody
production and decay with age, as well as the absolute
amount of antibodies produced by plasma cells, may cause
significant differences in the quantity of antibody over time,
independently of effects from previous exposure (Figure 5).
Conclusion
This review focuses on the observation that infants,
young and older children, adolescents, and adults each
Figure 4 Rate of antibody decay. Children of different ages have different initial levels of antibodies, and the antibodies decay at different
rates [43,118,121].


























Figure 5 Antibody production in children and adults.A
conceptual diagram of antibody levels in children and adults. First,
the rate of production is slower in children than adults. Then, the
total overall amount produced is lower in children than adults.
Finally, the antibodies decay at a faster rate in children than adults.
Combined, these effects may have a significant impact on the
ability of children to target Plasmodium falciparum antigens.
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Page 9 of 13show markedly different susceptibility, clinical manifes-
tations, and morbidity and mortality with respect to
malaria. While exposure, and thus acquired immunity,
may vary with age, studies suggest that a number of
independent age-related factors may help to explain
these differences.
Malaria affects many organs, each of which play a role in
the protection from, development of, and presentation of
malaria infection. Well-documented developmental
changes in immunity may play a major role in the suscept-
ibility of infants and young children to malaria, but other
developmental changes in the liver, spleen, blood cells and
blood flow occur at ages that correspond to noted changes
in malaria susceptibility and manifestations. The relative
impact of these anatomic and physiologic developmental
changes, alone or in combination, has not yet been sys-
tematically examined. However, if the aim of a malaria
vaccine is to shift the response of a young child to that of
an older child - i.e. to minimize the frequency and severity
of clinical episodes - then expectations must be calibrated
to allow for the effects of development that arise with age
per se, as well as with exposure.
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